0743 GMT - Investors are likely to take well to AB InBev's better-than-expected and "well-rounded" 2025 update, analysts at JPMorgan write in a note to clients. The Belgian brewer of Bud Light, Michelob and Corona booked better-than-expected volumes and Ebitda growth, and set out a fairly cheery outlook for 2026. "While the stock has outperformed over the past three months, we would expect the shares to be supported given the recovery in major markets," JPM says. The investment bank has an overweight rating and a 73-euro target price on the Brussels-listed stock. (joshua.kirby@wsj.com; @joshualeokirby)
(END) Dow Jones Newswires
February 12, 2026 02:43 ET (07:43 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.